Daclizumab Subcutaneous and Naphazoline and pheniramine ophthalmic
Determining the interaction of Daclizumab Subcutaneous and Naphazoline and pheniramine ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: naphazoline / pheniramine ophthalmic
Brand name: Naphcon-A, Opcon-A, Visine-A, AK-Con-A, Ocuhist
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Naphazoline Hydrochloride
- Daclizumab Subcutaneous-Naphazoline nasal
- Daclizumab Subcutaneous-Naphazoline ophthalmic
- Daclizumab Subcutaneous-Naphcon
- Daclizumab Subcutaneous-Naphcon Forte
- Daclizumab Subcutaneous-Naphcon-A
- Naphazoline and pheniramine ophthalmic-Dacogen
- Naphazoline and pheniramine ophthalmic-Dacomitinib
- Naphazoline and pheniramine ophthalmic-Dactinomycin
- Naphazoline and pheniramine ophthalmic-Dactinomycin Injection
- Naphazoline and pheniramine ophthalmic-Dactinomycin Intravenous
- Naphazoline and pheniramine ophthalmic-Daklinza